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Abstract
Background: Breast cancer in the Middle-East occurs in relatively young women and frequently
presents as advanced disease. A protective effect of multiparity is not apparent, and high familial
risk is reported in some countries. This study investigates breast cancer rates and clinical stage
related to age in the Kurdish region of Iraq and evaluates risk associated with parity and family
history. Findings are compared with nearby countries and the West.
Methods: Sulaimaniyah Directorate of Health records identified 539 women diagnosed with
breast cancer during 2006-2008. Clinical survey forms were completed on 296 patients and on 254
age-matched controls. Age specific incidence rates were calculated from Directorate of Health
population estimates.
Results: Average patient age was 47.4 ± 11 years and 59.5% were pre-menopausal. Diagnosis was
at clinical stage 1 for 4.1%, stage 2 for 43.5%, stage 3 for 26.0%, and stage 4 for 8.1% of patients.
For 18.2%, stage was unknown. Annual breast cancer incidence rates per 100,000 women peaked
at 168.9 at age 55 to 59 and declined to 57.3 at 60 and above. Patients had an average of 5.0 ± 3.3
children compared to 5.4 ± 3.5 for controls, P = 0.16. A first degree family member had breast
cancer among 11.1% of patients and 2.1% of controls (P < 0.001) with > 50% of these patients and
controls being ≥50 years old. No statistically significant relationship was found between tumor
stage and age, P = 0.59.
Conclusions: In Kurdish Iraq, breast cancer is predominantly a disease of pre-menopausal women
having multiple pregnancies. For younger patients, breast cancer incidence was similar to the West
and possibly higher than many Middle-Eastern countries, but unlike the West, the estimated rates
declined markedly in the elderly. The familial breast cancer risk for both older and younger women
was within the general population risk of Western countries. Clinical stages were advanced and
indicated delays in diagnosis that were unrelated to patient age.
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Background
The incidence of breast cancer appears to be increasing
world-wide [1]. The increase in Western countries is well
documented and is paralleled by stable or declining breast
cancer mortality. These divergent findings are presumed
to be due to more effective therapies and to an early detec-
tion of small tumors [2]. In non-Western countries accu-
rate epidemiologic data is difficult to collect, but breast
cancer may also be increasing in less developed regions of
the world [2].
In both the Middle-East and the West, carcinoma of the
breast is the most common malignancy of women. In the
West, there is a cultural tendency toward late marriages
and limited childbearing. In this setting, multiparity and
breast feeding are protective against breast cancers that are
predominantly found after the menopause [2]. In the
Middle-East, breast cancer is frequently seen during the
childbearing years [2,3]. Studies on breast cancer rates and
risk factors in the Middle-East are limited, but Egypt is
thought to have the highest rates in the Middle-East with
the increase being primarily between 30 to 60 years of age
[2,4].
A case control study from Iran did not shown any relation-
ship between parity and breast cancer among 286 patients
whose average age at diagnosis in 1997-1998 was 47.5 ±
12.5 years [5,6]. The investigators did, however, find a sig-
nificantly increased risk among women who were never
married and among women with a positive family history
of breast cancer. They also found that the great majority of
patients were diagnosed with advanced disease, and that
many patients had a significant delay between their recog-
nition of symptoms and their first medical consultation
for the condition.
In this initial study of breast cancer in the Kurdish region
of northern Iraq, we investigated age specific cancer rates
within Sulaimaniyah province. In an age-matched case
control study, we evaluated the risks associated with
reproductive history and family breast cancer history. We
additionally analyzed the relationships between patient
age and clinical stage as a means of assessing tumor
behavior in older and younger women. The aims of the
study were to compare breast cancer rates, the severity of
disease, and risk associated with reproductive and family
history with published investigations from other Middle-
Eastern countries and from the United States.
Methods
The Sulaimaniyah Directorate of Health serves as the eth-
ics committee for Hewa Hospital. The Directorate of
Health gave permission for the research, and patient inter-
actions were conducted according to the Helsinki Accords.
In 2005, the Directorate of Health established Hewa
Hematology and Oncology Hospital as the central institu-
tion for collecting data on cancer patients and coordinat-
ing cancer care in the region. In the years 2006 through
2008, 539 women were reported as having a first diagno-
sis of breast cancer. Registry included age, place of resi-
dence, and the record of the histologic confirmation of
diagnosis. Among the 539 women, 296 were treated at
Hewa Hospital where detailed clinical records were avail-
able and patients could be interviewed during clinic visits.
All 296 patients gave oral consent to be interviewed by
RAM, HAM, or BMS. The remaining 243 patients were
treated at other regional facilities. Additional records
beside registration were not available at Hewa Hospital,
and patients were not further contacted.
The interview used a structured clinical survey form that
included age and menstrual status at the time of diagno-
sis, marital status, height, weight, number of children, age
at first pregnancy, and family history of breast cancer with
the relationships to affected family members. Height and
weight were measured during the initial clinical examina-
tions. The records of 242 patients contained an assign-
ment of tumor stage at the time of diagnosis. For 54
patients, the extent of disease was unknown.
The questionnaires used for patients were also used for
254 control subjects attending general (non-obstetrical)
ambulatory facilities unrelated to Hewa Hospital. Control
subjects had no history of cancer. The numbers of control
subjects were matched for the number of patients in each
five year interval from 20 to 80 years old. The population
and age distribution of male and female citizens of
Sulaimaniyah Governate were obtained from the Division
of Vital Statistics of the Directorate of Health.
Data were entered into an Excel worksheet and were ana-
lyzed with Stata software (Stata Corp., College Station,
TX). Between groups comparisons were analyzed by t-tests
if data met normality and equal variance tests and by
Mann-Whitney rank-sum tests if they did not. Kol-
mogorov-Smirnov tests were applied to determine
whether data were normally distributed. For the age
grouped patients and controls, conditional logistic regres-
sion was used to analyze the observed risk of breast cancer
(outcome) conferred by the predictors of marital status
and number of children. The relationship between tumor
stage and patient age was tested by linear regression and
differences between groups for categorical values by chi-
square tests. For all statistical procedures, P < 0.05 was
considered statistically significant.
Results
In 2006-2008, the following numbers of women were
diagnosed with breast cancer: 188 patients in 2006, 205
patients in 2007, and 149 patients in 2008. The estimatedBMC Women's Health 2009, 9:33 http://www.biomedcentral.com/1472-6874/9/33
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Sulaimaniyah female population for 5 year age ranges
from 20 though 75+ years and the annual age specific
breast cancer incidence for the region are shown in Table
1. This is compared with published data for Israeli Arabs,
Jordan, Egypt, and for the United States [2,3]. The Kurdish
incidence rates exceeded those for Israeli Arab and Jorda-
nian women and were similar to Egyptian women begin-
ning at age 35-39. Kurdish rates reached a peak of 168.9
per 100,000 at 55-59 and then declined markedly to
where they were less than half that for Jordanian, Israeli
Arab, and Egyptian women at age 70-74 and approxi-
mately one-third of the rates for those regions at 75 years
of age and above.
The clinical characteristics of patients and case controls
are shown in Table 2. The average age of breast cancer
patients was 47.4 ± 11.0 years with a median age of 46 and
the 25th and 75th percentiles being 39 and 55 years old
respectively. The proportion of patients reporting that
they were menstruating at the time of diagnosis and who
were designated as pre-menopausal was 59.5%. There
were no significant differences between breast cancer
patients and controls in BMI, marital status, and number
of pregnancies. The average BMI was in the overweight
category, but the median BMI was just above normal
weight at 26.7 kg/m2 and the 25th and 75th percentiles
were 24.4 and 30.3 kg/m2  respectively. Breast cancer
patients  ≥50 years old had significantly fewer children
than the same aged control subjects (P  = 0.001), and
breast cancer patients ≥50 years old were more often nul-
ligravida than controls with this difference tending toward
but not being significant. By conditional logistic regres-
sion, the independent variables of marital status (P  =
0.76) and number of children (P = 0.08) were not signifi-
cant predictors of breast cancer, although the number of
children approached significance. The regression coeffi-
cient suggests a trend for fewer children being related to
breast cancer (r = -0.063, 95%CI: -.0.132 to 0.006) with
this effect being seen in subjects ≥50 years old (P = 0.03, r
= -0.111, 95%CI: -0.210 to -0.012) but not < 50 years of
age (P = 0.77, r = -0.015, 95%CI: -0.114 to 0.084).
Patients reported that a family member with any degree of
relationship had breast cancer in 19.0% of cases com-
pared to 7.1% of controls (OR 3.25, 95%CI: 1.82 to 5.79,
P < 0.001). A first degree family member (mother or sis-
ter) had breast cancer among 11.1% of patients and 2.1%
of controls (OR 5.85, 95%CI: 2.21 to15.46, P < 0.001).
For subjects having an affected first degree family mem-
ber, 14 out of 27 patients (51.9%) and 3 out of 5 controls
Table 1: Estimated age specific incidence (annual × 100,000) for breast cance in the Sulaimaniyah Governate and comparison with 
other Middle-Eastern countries and the United States [2,3].
age Patients* Population Sulaimaniyah Israeli Arabs Jordan Egypt US
20-24 y 2 82,206 0.8 0.0 0.8 1.4 1.3
25-29 y 13 80,746 5.5 8.7 5.7 9.8 7.1
30-34 y 34 62,706 18.1 11.8 20.8 28.9 25.2
35-39 y 63 37,634 55.8 35.2 47.1 63.6 61.7
40-44 y 83 26,768 103.4 53.4 73.6 96.7 117.5
45-49 y 89 23,502 126.2 93.5 82.6 144.9 192.1
50-54 y 84 20,156 138.9 104.2 129.3 171.5 253.1
55-59 y 77 15,200 168.9 124.0 114.6 181.2 332.4
60-64 y 32 14,197 75.1 144.0 134.8 144.2 386.8
65-69 y 34 12,123 93.4 136.8 131.1 105.0 431.1
70-74 y 17 12,419 45.6 118.7 103.0 94.1 458.7
75+ y 11 15,970 22.9 96.4 77.6 99.6 458.7
*The number of women reported as having breast cancer in the Sulaimaniyah Governate during the 3 year period 2006-2008.
Population: estimates by age for Sulaimaniyah Governate.
Abbreviation: US, United StatesBMC Women's Health 2009, 9:33 http://www.biomedcentral.com/1472-6874/9/33
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were ≥50 years old. The odds ratio for patients having a
first degree family member with breast cancer was similar
for older and younger patients (≥50 years old, OR 5.21,
95%CI: 1.45 to 18.77, P = 0.01; < 50 years old, OR 6.89,
95%CI: 1.53 to 31.13, P = 0.01).
Table 3 shows the distribution of clinical stage among 296
surveyed patients. Just 4.1% of patients were diagnosed
with stage 1 breast cancer; while 69.5% of patents had
clinical stage 2 or stage 3 disease, and 8.1% had confirmed
distant metastases. For patients with a designated stage,
there was no significant relationship between tumor stage
and age (r = -0.002, 95%CI: -0.011 to 0.006, P = 0.59) nor
was the relationship significant when patients whose stage
was unknown were included (r = -0.009, 95%CI: -0.022 to
0.003, P = 0.13).
Discussion
In this study, the age specific annual incidence rates of
breast cancer for women between 35 to 59 years of age
were higher among Iraqi Kurds than for Israeli Arabs and
Jordanians and were similar to Egyptians [2]. However at
age 60, the Kurdish breast cancer rates fell abruptly and at
70 years of age and above they were less than half that of
Jordanians, Israeli Arabs, or Egyptians.
The completeness of the registration of incident breast
cancer patients is a concern. Beginning in 2005, the Direc-
torate of Health centralized the registration of cancer
patients at the Hewa regional Hematology and Oncology
Hospital. Some patients have the financial means to seek
private care outside of Iraq and never register. Other per-
sons never register because they do not want further med-
ical care once a diagnosis of cancer is made. Although
there are no supporting data to substantiate the estimate,
Table 2: Clinical characteristics of patients at the time of diagnosis and of controls. Controls are matched with patients for age.
Breast cancer n = 296 Controls n = 254 P
Age 47.4 ± 10.9 46.9 ± 12.7 0.65
Pre-menopausal 59.5% 55.9% 0.75
BMI 27.7 ± 5.0 27.1 ± 4.3 0.16
≥50 years old 39.5% 41.3% 0.84
Married 84.1% 91.7% 0.53
Never married ≥50 y 6.8% 5.7% 0.96
Nulligravida 13.9% 10.6% 0.38
Nulligravida ≥50 y 9.4% 2.8% 0.11
Children 5.0 ± 3.3 5.4 ± 3.5 0.16
Children, patients ≥50 y 6.1 ± 3.3 7.6 ± 3.3 0.001
History of mother or sister having breast cancer 11.1% 2.1% < 0.001
History of mother or sister having breast cancer
Patients ≥50 y
14.1% 3.1% 0.02
Values for age, BMI, and number of children are mean ± standard deviation.
Table 3: Distribution of clinical stages.
All patients ≥50 years old
Clinical Stage
Stage 1 12 (4.1%) 2 (1.7%)
Stage 2 129 (43.5%) 58 (49.6%)
Stage 3 77 (26.0%) 21 (17.9%)
Stage 4 24 (8.1%) 13 (11.1%)
Unknown 54 (18.2%) 23 (19.7%)
Total 296 117BMC Women's Health 2009, 9:33 http://www.biomedcentral.com/1472-6874/9/33
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the proportion of non-registrants is thought to be 10 to
15%. This is an area that needs further investigation, and
it is important to recognize that breast cancer rates
throughout the Middle-East are very likely to be substan-
tially underestimated compared to the West.
The fall in breast cancer rates for older Kurdish women
could be due to age-selective non-referral for registration.
Since 2005, there have been public efforts to promote
breast cancer awareness. The low numbers of patients ≥60
years of age may be the result of these efforts not reaching
or not being applied to the older population. On the other
hand, the lower rates of breast cancer after age 60 could be
the effect of multiparity actually reducing breast cancer
development after the menopause.
Patient recognition and the clinical detection of breast
tumors did not seem to be any better in older compared
to younger women. Without regard to age, only 4.1% of
patients had their breast cancers discovered as localized
tumors; whereas, 69.5% were diagnosed at clinical stage 2
or 3 of the disease. Because of the lack of access to ade-
quate radiologic procedures, stage 4 may have been under
diagnosed at 8.1% of patients, and 18.2% of patients were
referred to oncological services with insufficient informa-
tion for a clinical stage to be assigned. In the United States,
a contrasting majority of 61% of patients is diagnosed
with stage 1 breast cancer, and in only 2% is stage
unknown [3]. In all probability, the advanced stage at
which tumors were found was the result of delayed diag-
nosis owing to a lack of adequate screening together with
a cultural reluctance to seek earlier care. Nevertheless, on
the basis of the similarity in clinical stage in older and
younger women, age did not seem to influence whether
patients took advantage of the care that was available.
These Iraqi breast cancer patients had an age distribution
that was nearly the same as that seen in Iran, Egypt, Jor-
dan, and among Israeli Arabs [2,5,6]. In all of these Mid-
Eastern countries the average and median age at diagnosis
is less than 50 and 25% of patients are younger than 41
years old. This compares with women in the United States
where the median age at diagnosis is 61 years of age, 65%
are 55 or older, and only 10.6% are younger than 44 years
old [3].
Iraqi patients averaged more than five completed preg-
nancies before diagnosis. In the West where Caucasian
women tend to have few children later in life, increased
numbers of children reduce overall breast cancer risk but
have little effect on tumor development before the meno-
pause [7,8]. In contrast, African Americans on average
have more children at an earlier age than Caucasians, and
studies on African American women have shown a dual
effect of childbearing on breast cancer risk [9]. While risk
is reduced with increased parity for women ≥45 years of
age, increased parity increases the risk of breast cancer in
women less than 45 years old. We found that Sulaimani-
yah patients ≥50 years old who were diagnosed with
breast cancer were more often nulligravida and had signif-
icantly fewer children than controls of the same age, sug-
gesting that reduced parity may increase breast cancer risk
in older Kurdish women.
Age specific breast cancer incidence rates for Jordanian
and Israeli Arab women lag 25 to 50% behind those in the
United States until 40 to 44 years of age [2]. Thereafter,
rates of breast cancer in the United States begin to double,
and by age 65 they are more than 3 times the rates
reported in the Middle-East including Egypt. The tradi-
tional culture of the Middle-East encouraged large fami-
lies. The comparatively lower rates of breast cancer among
older Middle-Eastern Arabs and Kurds could be a cohort
effect due to increased childbearing having a protective
effect on earlier generations of women.
There was an increased risk of breast cancer among Kurd-
ish patients who had a positive family history compared
to case controls. Nevertheless, the 11.1% of patients hav-
ing a first degree relative with breast cancer was very simi-
lar to the proportions seen in two large prospective United
States studies where 6.8% of the general population and
11.6% of breast cancer patients reported an affected
mother or sister [10,11]. In Western countries, 5 to10% of
all adult women have a first degree relative with breast
cancer, and a positive family history for up to 17% of
women for any degree of relationship is considered to be
near the lifetime population risk [10-13].
Although 19% of Kurdish breast cancer patients gave a
familial history of breast cancer, by Western standards this
is not particularly high, and it is balanced by what appears
to be a low familial breast cancer rate of 7.1% among case
control subjects. In addition, the risks for both patients
and controls were nearly equally distributed by age and
did not seem to be a factor in a possible excess of cancers
among pre-menopausal women.
Mammography is the principal tool for screening for
breast cancer in Western medicine. The alternatives to
mammography are clinical breast examinations and mag-
netic resonance imaging (MRI) with current evidence not
justifying recommendations for either of these two meth-
ods as screening investigations [14,15]. Mammography
significantly reduces breast cancer mortality for women
aged 50 to 69 and to a lesser degree for women 40 to 49
years old [14]. The selective application of MRI may
improve breast cancer detection in younger patients, andBMC Women's Health 2009, 9:33 http://www.biomedcentral.com/1472-6874/9/33
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the American Cancer Society currently recommends MRI
as an adjunct to screening mammography in high risk
women ≥30 years old [16-18].
At the present time, there are no established breast cancer
screening programs in the Kurdish region of Iraq. Recom-
mendations are being formulated, but mammography is
only available for patients referred to the University Hos-
pitals in Sulaimaniyah, Erbil, and Dohuk and at a few pri-
vate radiology facilities. It will take several years before
meaningful mortality data will be available for our Kurd-
ish population, but as screening is implemented, reduc-
tions in clinical stage might serve as a short-term measure
of interventional programs.
Conclusions
Breast Cancer in Kurdish women of Sulaimaniyah Iraq is
currently diagnosed at advanced clinical stages with 60%
of patients being under 50 years of age. Until approxi-
mately age 45, age specific incidence rates were similar to
those of Egypt and the United States and were higher than
reported for Israeli Arabs and Jordanians. These findings
suggest that breast cancer risk for pre-menopausal Iraqi
Kurds may be unusually high for a Middle-Eastern coun-
try. The cause of these seemingly higher pre-menopausal
breast cancer rates could not be related to parity or to an
excessive familial risk. Interventional programs need to be
directed toward methods that will reduce clinical stage of
disease in younger women, but the best approach to cost
effective screening in our region is not readily apparent.
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